Solar ultraviolet radiation exposure, and incidence of childhood acute lymphocytic leukaemia and non-Hodgkin lymphoma in a US population-based dataset
British Journal of Cancer, Published online: 29 February 2024; doi:10.1038/s41416-024-02629-3Solar ultraviolet radiation exposure, and incidence of childhood acute lymphocytic leukaemia and non-Hodgkin lymphoma in a US population-based dataset (Source: British Journal of Cancer)
Source: British Journal of Cancer - February 29, 2024 Category: Cancer & Oncology Authors: Mark P. Little Jim Z. Mai Michelle Fang Pavel Chernyavskiy Victoria Kennerley Elizabeth K. Cahoon Myles G. Cockburn Gerald M. Kendall Michael G. Kimlin Source Type: research
Ranolazine: a potential anti-metastatic drug targeting voltage-gated sodium channels
British Journal of Cancer, Published online: 29 February 2024; doi:10.1038/s41416-024-02622-wRanolazine: a potential anti-metastatic drug targeting voltage-gated sodium channels (Source: British Journal of Cancer)
Source: British Journal of Cancer - February 29, 2024 Category: Cancer & Oncology Authors: Mustafa B. A. Djamgoz Source Type: research
Risk of cancer and serious disease in Danish patients with urgent referral for serious non-specific symptoms and signs of cancer in Funen 2014–2021
British Journal of Cancer, Published online: 26 February 2024; doi:10.1038/s41416-024-02620-yRisk of cancer and serious disease in Danish patients with urgent referral for serious non-specific symptoms and signs of cancer in Funen 2014–2021 (Source: British Journal of Cancer)
Source: British Journal of Cancer - February 26, 2024 Category: Cancer & Oncology Authors: Rasmus Birkholm Gr ønnemose Per Syrak Hansen S øren Worsøe Laursen Oke Gerke Jakob Kjellberg Jesper Lykkegaard Clara Thye-R ønn Poul Flemming H øilund-Carlsen Peter Thye-R ønn Source Type: research
Comment on “Dexamethasone-sparing on days 2–4 with combined palonosteron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial)”
British Journal of Cancer, Published online: 26 February 2024; doi:10.1038/s41416-024-02611-zComment on “Dexamethasone-sparing on days 2–4 with combined palonosteron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial)” (Source: British Journal of Cancer)
Source: British Journal of Cancer - February 26, 2024 Category: Cancer & Oncology Authors: Luigi Celio Andrea Antonuzzo Matti S. Aapro Source Type: research
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database
British Journal of Cancer, Published online: 24 February 2024; doi:10.1038/s41416-024-02604-yFluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database (Source: British Journal of Cancer)
Source: British Journal of Cancer - February 24, 2024 Category: Cancer & Oncology Authors: C. S. Karapetis H. Liu M. J. Sorich L. D. Pederson E. Van Cutsem T. Maughan J. Y. Douillard C. J. O ’Callaghan D. Jonker C. Bokemeyer A. Sobrero C. Cremolini B. Chibaudel J. Zalcberg R. Adams M. Buyse M. Peeters T. Yoshino A. de Gramont Q. Shi Source Type: research
Capivasertib combines with docetaxel to enhance anti-tumour activity through inhibition of AKT-mediated survival mechanisms in prostate cancer
British Journal of Cancer, Published online: 23 February 2024; doi:10.1038/s41416-024-02614-wCapivasertib combines with docetaxel to enhance anti-tumour activity through inhibition of AKT-mediated survival mechanisms in prostate cancer (Source: British Journal of Cancer)
Source: British Journal of Cancer - February 23, 2024 Category: Cancer & Oncology Authors: Cath Eberlein Stuart C. Williamson Lorna Hopcroft Susana Ros Jennifer I. Moss James Kerr Wytske M. van Weerden Elza C. de Bruin Shanade Dunn Brandon Willis Sarah J. Ross Claire Rooney Simon T. Barry Source Type: research
Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro
British Journal of Cancer, Published online: 23 February 2024; doi:10.1038/s41416-024-02608-8Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro (Source: British Journal of Cancer)
Source: British Journal of Cancer - February 23, 2024 Category: Cancer & Oncology Authors: Qiyu Cao Annika Hajosch Richard Eric Kast Christopher Loehmann Michal Hlavac Pamela Fischer-Posovszky Hannah Strobel Mike-Andrew Westhoff Markus D. Siegelin Christian Rainer Wirtz Marc-Eric Halatsch Georg Karpel-Massler Source Type: research
A prospective study of birth weight and prostate cancer risk and mortality in the Health Professionals Follow-up Study
British Journal of Cancer, Published online: 22 February 2024; doi:10.1038/s41416-024-02593-yA prospective study of birth weight and prostate cancer risk and mortality in the Health Professionals Follow-up Study (Source: British Journal of Cancer)
Source: British Journal of Cancer - February 22, 2024 Category: Cancer & Oncology Authors: Qinran Liu Yiwen Zhang Jane B. Vaselkiv Lorelei A. Mucci Edward L. Giovannucci Elizabeth A. Platz Siobhan Sutcliffe Source Type: research
Age at lung cancer diagnosis in females versus males who never smoke by race and ethnicity
British Journal of Cancer, Published online: 22 February 2024; doi:10.1038/s41416-024-02592-zAge at lung cancer diagnosis in females versus males who never smoke by race and ethnicity (Source: British Journal of Cancer)
Source: British Journal of Cancer - February 22, 2024 Category: Cancer & Oncology Authors: Batel Blechter Jason Y. Y. Wong Li-Hsin Chien Kouya Shiraishi Xiao-Ou Shu Qiuyin Cai Wei Zheng Bu-Tian Ji Wei Hu Mohammad L. Rahman Hsin-Fang Jiang Fang-Yu Tsai Wen-Yi Huang Yu-Tang Gao Xijing Han Mark D. Steinwandel Gong Yang Yihe G. Daida Su-Ying Liang Source Type: research
CAnceR IN PreGnancy (CARING) – a retrospective study of cancer diagnosed during pregnancy in the United Kingdom
British Journal of Cancer, Published online: 21 February 2024; doi:10.1038/s41416-024-02605-xCAnceR IN PreGnancy (CARING) – a retrospective study of cancer diagnosed during pregnancy in the United Kingdom (Source: British Journal of Cancer)
Source: British Journal of Cancer - February 21, 2024 Category: Cancer & Oncology Authors: M. A. Baxter M. Denholm S. J. Kingdon S. Kathirgamakarthigeyan S. Parikh R. Shakir R. Johnson H. Martin M. Walton W. Yao A. Swan C. Samuelson X. Ren A. Cooper H-L Gray S. Clifton J. Ball G. Gullick M. Anderson L. Dodd H. Hayhurst M. Salama R. Shotton F. B Source Type: research
Comment on “Pathological complete response, category change, and prognostic significance of HER2-low breast cancer receiving neoadjuvant treatment: a multicenter analysis of 2489 cases”
British Journal of Cancer, Published online: 20 February 2024; doi:10.1038/s41416-024-02616-8Comment on “Pathological complete response, category change, and prognostic significance of HER2-low breast cancer receiving neoadjuvant treatment: a multicenter analysis of 2489 cases” (Source: British Journal of Cancer)
Source: British Journal of Cancer - February 20, 2024 Category: Cancer & Oncology Authors: Tianfei Yu Changfei Yang Ming Li Source Type: research
Cyclin-dependent kinase 7 (CDK7) inhibitors as a novel therapeutic strategy for different molecular types of breast cancer
British Journal of Cancer, Published online: 14 February 2024; doi:10.1038/s41416-024-02589-8Cyclin-dependent kinase 7 (CDK7) inhibitors as a novel therapeutic strategy for different molecular types of breast cancer (Source: British Journal of Cancer)
Source: British Journal of Cancer - February 14, 2024 Category: Cancer & Oncology Authors: Xue Song Chen Fang Yan Dai Yang Sun Chang Qiu Xiaojie Lin Rui Xu Source Type: research
Stratifying ICIs-responsive tumor microenvironment in HCC: from parsing out immune-hypoxic crosstalk to clinically applicable MRI-radiomics models
British Journal of Cancer, Published online: 14 February 2024; doi:10.1038/s41416-023-02463-zStratifying ICIs-responsive tumor microenvironment in HCC: from parsing out immune-hypoxic crosstalk to clinically applicable MRI-radiomics models (Source: British Journal of Cancer)
Source: British Journal of Cancer - February 14, 2024 Category: Cancer & Oncology Authors: Li-Na Song Biao Wang Jia-Liang Cai Pei-Ling Zhang Shi-Ping Chen Zheng-Jun Zhou Zhi Dai Source Type: research
Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer
British Journal of Cancer, Published online: 14 February 2024; doi:10.1038/s41416-024-02606-wCorrection: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer (Source: British Journal of Cancer)
Source: British Journal of Cancer - February 14, 2024 Category: Cancer & Oncology Authors: Theodora A. Constantin Anabel Varela-Carver Kyle K. Greenland Gilberto Serrano de Almeida Ellen Olden Lucy Penfold Simon Ang Alice Ormrod Damien A. Leach Chun-Fui Lai Edward K. Ainscow Ash K. Bahl David Carling Matthew J. Fuchter Simak Ali Charlotte L. Be Source Type: research
Low-dose aspirin use and risk of ovarian cancer: a combined analysis from two nationwide studies in Denmark and Sweden
British Journal of Cancer, Published online: 12 February 2024; doi:10.1038/s41416-024-02609-7Low-dose aspirin use and risk of ovarian cancer: a combined analysis from two nationwide studies in Denmark and Sweden (Source: British Journal of Cancer)
Source: British Journal of Cancer - February 12, 2024 Category: Cancer & Oncology Authors: Guoqiao Zheng Mette Tuxen Faber Jiangrong Wang Louise Baandrup Rasmus Hertzum-Larsen Karin Sundstr öm Susanne K. Kj ær Source Type: research
